Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung CancerBin Liu, Alicia Hulbert, Julio Ricarte Filho et al.|Clinical Cancer Research|2020Cited by 103
Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a STK11 mutationJosiah An, Taher Abu Hejleh, Melissa Yan et al.|Translational Lung Cancer Research|2021Cited by 10
Neighborhood-level deprivation and survival in lung cancerKathleen Kennedy, Alicia Hulbert, Ignacio Jusué-Torres et al.|BMC Cancer|2024Cited by 8
Phase Ib/II study of imprime PGG and pembrolizumab in patients with previously treated advanced non-small cell lung cancer (NSCLC): BTCRC LUN 15-017Muhammad Furqan, Lawrence Feldman, Jyoti Malhotra et al.|Translational Lung Cancer Research|2024Cited by 3
Figure S3 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung CancerBin Liu, Alicia Hulbert, Christian Ascoli et al.|Unknown|2023Cited by 0